| 摘要 |
The invention relates to a method of diagnosing or predicting a bladder cancer, or a risk of a developing a bladder cancer in a subject, which method comprises the detection of specific mutations in the FGFR3 gene in a first biological sample; and the measure of the degree of methylation of target genes in a biological sample obtained from said subject in a second biological sample, |
